Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors. [electronic resource]
Producer: 20190930Description: 1019-1029 p. digitalISSN:- 1460-2105
- Animals
- Capillary Permeability -- drug effects
- Cell Line, Tumor
- Disease Models, Animal
- Endothelium, Vascular -- drug effects
- Gene Expression
- Gene Expression Profiling
- Gold -- pharmacology
- Humans
- Mice
- Mice, Knockout
- Molecular Targeted Therapy
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Staging
- Neovascularization, Pathologic -- therapy
- Neuroendocrine Tumors -- genetics
- Pancreatic Neoplasms -- genetics
- Polyethylene Glycols -- pharmacology
- Recombinant Proteins
- Theranostic Nanomedicine
- Thyroid Neoplasms -- genetics
- Tumor Necrosis Factor-alpha -- pharmacology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.